Thu 20 Aug 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Scientific Name | Trade Name | Strength | Doesage Form | Price | Details |
|---|---|---|---|---|---|
| IRBESARTAN,HYDROCHLOROTHIAZIDE | IRBEGEN PLUS 150/12.5 mg Film Coated Tablet | 150,12.5 | 36 | Details | |
| IRBESARTAN,HYDROCHLOROTHIAZIDE | IRBEGEN PLUS 300/25 mg Film Coated Tablet | 300,25 | 47.70 | Details | |
| COLECALCIFEROL | VI-DAL 10000 I.U. Capsule | 10000 | 19.25 | Details | |
| COLECALCIFEROL | VI-DAL 50000 I.U. Capsule | 50000 | 32.05 | Details | |
| DOCETAXEL | TAXOTERE 20 MG/ML SOLUTION FOR INFUSION | 20 | 461.7 | Details | |
| DOCETAXEL | TAXOTERE 20 MG/ML SOLUTION FOR INFUSION | 20 | 1846.8 | Details | |
| DOCETAXEL | TAXOTERE 20 MG/ML SOLUTION FOR INFUSION | 20 | 3693.6 | Details | |
| CINACALCET | CINAC 30 MG FILM COATED TABLET | 30 | 268.05 | Details | |
| CINACALCET | CINAC 60 MG FILM COATED TABLET | 60 | 498 | Details | |
| CINACALCET | CINAC 90 MG FILM COATED TABLET | 90 | 734.4 | Details | |
| GOLIMUMAB | SIMPONI 100 MG/ML SOLUTION FOR INJECTION IN PREFILLED PEN | 100 | 5170.65 | Details | |
| AZILSARTAN MEDOXOMIL, CHLORTHALIDONE | EDARBYCLOR 80 MG/12.5 MG TABLET | 80, 12.5 | 71.45 | Details | |
| AZILSARTAN MEDOXOMIL, CHLORTHALIDONE | EDARBYCLOR 80 MG/25 MG TABLET | 80, 25 | 71.45 | Details | |
| TADALAFIL | HEROX 20 mg film-coated tablet | 20 | 160.1 | Details | |
| DEXMEDETOMIDINE | SEDALERT 100 MCG -ML IV. VIAL | 100 | 83.25 | Details | |
| MONTELUKAST SODIUM | LEUKAST 4 mg Granules | 4 | 77.1 | Details | |
| NOREPINEPHRINE BITARTRATE | NEVOLEEN 1 mg/ml Ampoule | 1 | 115.15 | Details | |
| CAPSAICIN | QUTENZA 179 mg Cutaneous Patch | 179 | 1117 | Details | |
| CAPSAICIN | QUTENZA 179 mg Cutaneous Patch | 179 | 2234 | Details | |
| LEVETIRACETAM | LEVETAM 100 mg/ml Oral Solution | 100 | 119.95 | Details |
7.14% of users said yes from 112 Response.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.